Understanding Cancer: A Patient's Guide to Diagnosis, Prognosis, and Treatment.

نویسنده

  • Merle O'Rourke Thompson
چکیده

C. Norman Coleman is an American Cancer Society Professor and Chairman of the Joint Center for Radiation Therapy at the Department of Radiation Oncology at Harvard Medical School. He is involved with cancer patients both as a clinician and a researcher. He is extensively experienced in the many aspects of medicine and oncology. He is board certified in internal medicine, medical oncology, and radiation oncology. He recognizes, however, that much of what he learns comes from the patients themselves. He has learned that "Achieving success in cancer care is best done with the patient as an integral part of a partnership." He believes that optimum results are achieved when patients take an active role in their treatment, making informed decisions together with their physicians. He thus wrote this book to arm patients with the knowledge they need to achieve this goal. Dr. Coleman states: "I wrote this guide for you and your family, so that you can be active partners with your health care providers."

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Scenario and future prospects of microRNAs in gastric cancer: A review

Carcinoma of the stomach is one of the major prevalent and principal causes of cancer-related deaths worldwide. Current advancement in technology has improved the understanding of the pathogenesis and pathology of gastric cancers (GC). But, high mortality rates, unfavorable prognosis and lack of clinical predictive biomarkers provide an impetus to investigate novel early diagnostic/prognostic m...

متن کامل

Diagnosis, Prognosis and Treatment of Peripheral Vascular Disease in Patients with Diabetic Foot Ulcer: Adopted IWGDF Guidance

Introduction: Peripheral arterial disease (PAD) is common in diabetic patients, and about half of the patients with diabetic foot ulcers (DFU) have concomitant peripheral arterial disease (PAD). The purpose of this study was to select an appropriate and comprehensive clinical guide in the management of DFU. The part of the practical guide that pertains to this is based on three systematic revie...

متن کامل

Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review

Pheochromocytomas (PCCs) are rare neuroendocrine tumors. The current diagnostic tools are based on biochemistry and histopathology results, but heterogeneity of diagnostic markers, signs and symptoms of PCCs bring a lot of difficulties for these two current methods. Unfortunately microscopic understanding of PCCs is not adequate for its confident prognosis and management. There are data linking...

متن کامل

Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations, Diagnosis, Follow-up, Histopathology and Prognosis

Background: Thyroid carcinoma is the most common malignancy of the endocrine system. Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, accounting for 70–90% of well-differentiated thyroid malignancies. Thyroid papillary microcarcinoma is a subtype of papillary carcinoma that included tumors with less than 10mm diameter. As a result of diagnostic methods improvement, p...

متن کامل

Diagnosis and prognosis disclosure to dying adult cancer patients part1, physician attitude

A total 119 physicians were interviewed to examine whether the diagnosis and prognosis of cancer should be communicated to terminally ill cancer patients. 53(44.5℅) of the physicians were not involved in the management of the patients who had recently died of cancer. 56(84℅) of the physicians who had patients didn't discuss the diagnosis and 62(93.9℅) the prognosis with their patients who had r...

متن کامل

Prognostic molecular markers in hepatocellular carcinoma (Review article

Hepatocellular carcinoma (HCC) is the 5th commonest malignancy worldwide and is the third most common cause of cancer-related death. The prevalence is different in the world. The ability to predict patients at higher risk of recurrence and with a poor prognosis would help to guide surgical and chemotherapeutic treatment according to individual risk. As understanding of hepatocarcinogenesi...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Journal of the National Cancer Institute

دوره 91 24  شماره 

صفحات  -

تاریخ انتشار 1999